v3.26.1
Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2026
Dec. 31, 2025
Current assets:    
Cash and cash equivalents $ 26,117 $ 28,647
Short-term investments 18,667 17,984
Accounts receivable, net 83,693 89,587
Inventory, net 92,539 92,746
Prepaid expenses and other current assets 7,968 9,102
Total current assets 228,984 238,066
Property and equipment, net 12,025 12,403
Other assets 5,207 5,408
Total assets 246,216 255,877
Current liabilities:    
Accounts payable 8,970 8,994
Accrued clinical and manufacturing liabilities 25,166 26,597
Accrued payroll and employee liabilities 6,390 9,270
Other accrued liabilities 49,990 51,237
Total current liabilities 90,516 96,098
Non-current notes payable, net 108,307 107,899
Non-current convertible notes payable, net 33,327 32,739
Other non-current liabilities 4,929 4,808
Total liabilities 237,079 241,544
Stockholders' equity:    
Common stock 1,886 1,883
Series A convertible preferred stock 1,050 1,050
Additional paid-in capital 1,954,107 1,951,185
Accumulated other comprehensive loss (6) 4
Accumulated deficit (1,947,900) (1,939,789)
Total stockholders' equity 9,137 14,333
Total liabilities and stockholders' equity $ 246,216 $ 255,877